Tag

tutina

2 minuti di lettura

EirGenix’s Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives

(Adnkronos) – TAIPEI, May 3, 2023 /PRNewswire/ — EirGenix, Inc. (6589.TT) announced on 28th of April that it has completed the phase 1 clinical trial (EGC101) of its second breast cancer biosimilar EG1206A

Immediapress

CGTN: How CPPCC proposals contribute to China’s policymaking

(Adnkronos) – BEIJING, March 4, 2023 /PRNewswire/ — In one proposal by members of the 13th National Committee of the Chinese People’s Political Consultative Conference (CPPCC), the country’s top political advisory body, efforts had been urged to consolidate poverty eradication

Former Head of Swiss Securities and Exchanges to head new Fintica AI Ltd Advisory Board

Immediapress

(Adnkronos) – New body to include industry experts: Thomas Zeeb, René Karsenti, Yanming Xiao TEL AVIV, Israel, April 13, 2023 /PRNewswire/ — Fintica AI

Maypharm Launches SEDY FILL, a hyaluronic acid body filler

Immediapress

(Adnkronos) – SEOUL, South Korea and NEW YORK, Aug. 9, 2023 /PRNewswire/ — Maypharm has launched SEDY FILL, a hyaluronic acid body filler maximized

tutina

EirGenix’s Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives

CGTN: How CPPCC proposals contribute to China’s policymaking

Former Head of Swiss Securities and Exchanges to head new Fintica AI Ltd Advisory Board

Maypharm Launches SEDY FILL, a hyaluronic acid body filler

Primo piano

Italia-Spagna, la sospensione di Schengen non sarà rinnovata

Blocco Tir, governo “sblocca” in Sicilia e Calabria, ma il Golfo di Napoli a rischio isolamento

Dopo gli scontri: cosa prevede il decreto e quali poteri hanno i militari

Il gioco sporco de “la Repubblica” che evoca il Cile di Pinochet in Italia

Schlein: “Serve prevenzione non repressione su sicurezza. Colle ha stoppato poteri ai militari” | Video

Sponsor

Suggerimenti

tutina

Primo piano

Sponsor